Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Evofem Biosciences, Inc. (EVFM)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 0.7 | 0.5 | 0.1 | | | | | |
| Asset turnover | 0.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | | | | | | | | -11272.9% |
| ROIC (including intangibles) | 118.1% | 162.8% | 753.0% | -6252.7% | 377.4% | 35.5% | -1191.6% | 2009.7% |
| ROE | 117.2% | 167.5% | -7693.2% | -337.3% | 332.4% | 35.8% | -101.1% | -176.6% |
| ROA | -334.5% | -392.4% | -94.2% | -186.4% | -1936.2% | -903.0% | -94.0% | -104.8% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 24.4 | 285.5 | 873.2 | | | | | |
| Days payables outstanding | 1,238.8 | 928.6 | 8,299.1 | | | | | |
| Days inventory outstanding | 444.7 | 690.8 | 5,585.7 | | | | | |
| Cash conversion cycle | -769.7 | 47.7 | -1,840.1 | | | | | |
|